Founded in 1985, the client is the largest, most innovative and comprehensive orthopaedic and neurological business in the world. The organization offers an unparalleled breadth and depth of products and services for joint reconstruction, trauma, spine, sports medicine, neurological, craniomaxillofacial, power tools for medical procedures, and biomaterials.
This broad portfolio supports nearly one million medical procedures annually across the globe. With a focus on activating insights to develop innovative, comprehensive solutions, the client is inspired to advance patient care.
In 2012, the client acquired a global medical device company and combined the franchises. Today, the client employs over 18,000 people across 60 countries and generates $10 billion in annual sales.
After acquiring a medical device company, the client needed to ensure regulatory remediation and integrate the new business unit into the corporate compliance program. In addition to hiring the required internal resources, the client wanted to identify the right project leader with strong remediation, compliance enforcement, and outside the US (OUS) experience. This would allow the client to file the acquired company’s products with the proper regulatory agencies under the client’s corporate identity.
Key Obstacles:
The Piper Life Sciences team implemented the Piper Engagement Process (PEP) as a partnership delivery solution. A transparent action plan built confidence by setting measurable expectations around the statement of work that would alleviate the challenges the client faced.